Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature
Objective: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the firs...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2021-03-01
|
| Series: | Dubai Medical Journal |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/513382 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846093862396755968 |
|---|---|
| author | Walaa A. Kamel Ismail Ibrahim Ismail Jasem Yousef Al-Hashel |
| author_facet | Walaa A. Kamel Ismail Ibrahim Ismail Jasem Yousef Al-Hashel |
| author_sort | Walaa A. Kamel |
| collection | DOAJ |
| description | Objective: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the first case from Kuwait, to the best of our knowledge. Clinical Presentation: A 72-year-old male presented with 3 weeks history of acute progressive and ascending lower limbs weakness. He developed these symptoms 3 weeks after testing positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Electrophysiological studies showed acute demyelinating polyradiculoneuropathy and cerebrospinal fluid showed protein-cell dissociation. He was successfully treated with intravenous immunoglobulins (IVIGs). Conclusion: Neurologists should be aware of GBS as a potentially serious complication associated with COVID-19. Our patient had a favorable outcome with IVIG with no autonomic or respiratory affection. |
| format | Article |
| id | doaj-art-94ada7f0b34a41ea9e9b9975cc740057 |
| institution | Kabale University |
| issn | 2571-726X |
| language | English |
| publishDate | 2021-03-01 |
| publisher | Knowledge E |
| record_format | Article |
| series | Dubai Medical Journal |
| spelling | doaj-art-94ada7f0b34a41ea9e9b9975cc7400572025-01-02T16:18:29ZengKnowledge EDubai Medical Journal2571-726X2021-03-01424610.1159/000513382513382Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the LiteratureWalaa A. Kamel0https://orcid.org/0000-0002-3363-0370Ismail Ibrahim Ismail1https://orcid.org/0000-0002-9788-7044Jasem Yousef Al-Hashel2Neurology Department, Ibn-Sina Hospital, Safat, KuwaitNeurology Department, Ibn-Sina Hospital, Safat, KuwaitNeurology Department, Ibn-Sina Hospital, Safat, KuwaitObjective: Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that is often related to a previous infectious exposure. GBS emerged as a potentially serious complication of coronavirus disease 2019 (COVID-19) since its declaration as a global pandemic. We report the first case from Kuwait, to the best of our knowledge. Clinical Presentation: A 72-year-old male presented with 3 weeks history of acute progressive and ascending lower limbs weakness. He developed these symptoms 3 weeks after testing positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Electrophysiological studies showed acute demyelinating polyradiculoneuropathy and cerebrospinal fluid showed protein-cell dissociation. He was successfully treated with intravenous immunoglobulins (IVIGs). Conclusion: Neurologists should be aware of GBS as a potentially serious complication associated with COVID-19. Our patient had a favorable outcome with IVIG with no autonomic or respiratory affection.https://www.karger.com/Article/FullText/513382coronaviruscovid-19peripheral neuropathyguillain-barre syndrome |
| spellingShingle | Walaa A. Kamel Ismail Ibrahim Ismail Jasem Yousef Al-Hashel Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature Dubai Medical Journal coronavirus covid-19 peripheral neuropathy guillain-barre syndrome |
| title | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
| title_full | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
| title_fullStr | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
| title_full_unstemmed | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
| title_short | Guillain-Barre Syndrome following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature |
| title_sort | guillain barre syndrome following covid 19 infection first case report from kuwait and review of the literature |
| topic | coronavirus covid-19 peripheral neuropathy guillain-barre syndrome |
| url | https://www.karger.com/Article/FullText/513382 |
| work_keys_str_mv | AT walaaakamel guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature AT ismailibrahimismail guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature AT jasemyousefalhashel guillainbarresyndromefollowingcovid19infectionfirstcasereportfromkuwaitandreviewoftheliterature |